查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1464654

生物程序驗證市場，按測試類型、按工藝組件、按最終用戶、按國家和地區 - 2024-2032 年行業分析、市場規模、市場佔有率和預測

Bioprocess validation Market, By Test Type, By Process Component, By End-User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 260 Pages | 商品交期: 2-3個工作天內

價格

報告要點

2023 年生物製程驗證市場規模為 4.2091 億美元，2024 年至 2032 年年複合成長率為 9.83%。

生物製程驗證市場-市場動態

外包生物製程驗證需求的激增和生命科學研發支出的增加預計將推動市場成長。

許多製藥和生物技術公司擴大委託其營運的各個方面，例如生物製程驗證。隨著生命科學領域研發活動的擴大，對生物製程驗證相關服務的需求不斷增加，以促進新生物製藥產品的開發和生產。全球研發支出已飆升至近1.7兆美元，其中約10個國家貢獻了80%的支出。根據聯合國教科文組織統計研究所 (UIS) 的數據，作為永續發展目標 (SDG) 的一部分，各國承諾在 2030 年大幅增加公共和私人研發支出以及研究人員數量。此外，生物加工技術和監管合規要求的進步可能為市場帶來成長機會。儘管如此，高昂的驗證成本可能會阻礙市場成長。

生物製程驗證市場 - 關鍵見解

根據我們的研究分析師分享的分析，預計全球市場在預測期內（2024-2032 年）每年將以 9.83% 左右的年複合成長率成長

根據測試類型細分，可萃取物和可浸出物測試預計將在 2023 年顯示最大的市場佔有率

依製程元件細分，2023年過濾元件為主導類型

根據最終用戶細分，製藥和生物技術公司是 2023 年的領先類型

按地區分類，北美是 2023 年的主要收入來源

生物製程驗證市場細分分析：

全球生物製程驗證市場根據測試類型、製程組件、最終用戶和地區進行細分。

根據測試類型，市場分為四組：可萃取物和可浸出物測試、生物製程殘留物測試、病毒清除測試、過濾和發酵系統測試等。市場上的主導類別是可萃取物和可浸出物測試。此類測試在藥品的開發和製造中發揮著至關重要的作用，特別是在生物製藥生產中使用的包裝材料、容器和加工設備方面。

根據製程組件，市場分為五類：過濾元件、介質容器和袋子、冷凍和解凍製程袋、混合系統、生物反應器、傳輸系統等。過濾元件是市場上的領先類別。它們在生物製藥製造過程中發揮著至關重要的作用，特別是在下游加工中。

根據最終用戶，市場分為三組：製藥和生物技術公司、合約開發和製造組織以及其他。市場的主導力量是製藥和生物技術公司。這些公司在推動生物製程驗證服務的需求方面發揮著重要作用。鑑於他們參與生物製藥產品的開發和生產，他們在製造過程中保持一致的品質並遵守監管標準至關重要。

生物製程驗證市場-地理洞察

從地理上看，該市場橫跨北美、拉丁美洲、歐洲、亞太地區、中東和非洲。這些區域根據對商業活動有貢獻的國家進一步細分。由於對生物製藥的需求不斷成長，預計該市場將主要由北美（特別是美國）推動。美國擁有強大且完善的生物製藥產業。生物製程驗證在確保生物製藥產品的品質、安全性和有效性方面發揮關鍵作用，導致對驗證服務和產品的需求不斷增加。根據《醫藥統計》，2021 年美國製藥業收入為 5,500 億美元，而美國人在藥品上的支出為 5,769 億美元。歐洲是第二大市場成長地區。

生物製程驗證市場-競爭格局：

由於生物製藥需求的不斷成長、生物製程技術的進步以及嚴格的監管標準，生物製程驗證市場正在經歷大幅成長。該市場的製造商不斷努力創新，創造用於驗證生物過程的尖端技術和方法。透過保持創新的前沿，這些公司透過提供更有效率、更準確和更具成本效益的驗證解決方案獲得了競爭優勢。此外，優先考慮客戶滿意度並建立牢固的消費者關係的公司通常會從重複業務和轉移中受益，從而進一步增強其競爭地位。

最近的發展：

Eurofins BioPharma 產品測試哥倫比亞公司是全球最大的統一生物/製藥GMP 產品測試設施網路的一部分，宣布與Plus Therapeutics, Inc.（“Plus Therapeutics”）達成合作協議，Plus Therapeutics 是一家臨床階段製藥公司，開發罕見病的新型標靶療法和困難的癌症。

2020 年 4 月 30 日，領先的科技公司 Merck 今天推出了其 BioContinuum 平台的下一個組件 Bio4C 軟體套件，打造了一個首個生態系統，將製程控制、分析以及植物級自動化。

目錄

第 1 章：生物製程驗證市場概述

  • 研究範圍
  • 市場預估年份

第 2 章：執行摘要

  • 市場片段
    • 按測試類型分類的生物程序驗證市場片段
    • 按工藝組件分類的生物程序驗證市場片段
    • 最終用戶的生物程序驗證市場片段
    • 按國家/地區分類的生物程序驗證市場片段
    • 按地區分類的生物程序驗證市場片段
  • 競爭洞察

第 3 章：生物製程驗證主要市場趨勢

  • 生物製程驗證市場促進因素
    • 市場促進因素的影響分析
  • 生物製程驗證市場限制
    • 市場限制影響分析
  • 生物製程驗證市場機會
  • 生物製程驗證市場未來趨勢

第 4 章：生物製程驗證產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第 5 章：生物製程驗證市場：COVID-19 影響分析

  • COVID-19 之前的影響分析
  • COVID-19 後影響分析
    • 表現最佳的市場區隔
    • 邊際成長市場區隔
    • 最寬鬆的市場區隔
    • 邊際損失市場區隔

第 6 章：生物製程驗證市場格局

  • 2023 年生物製程驗證市場佔有率分析
  • 按主要製造商分類的故障數據
    • 既有參與者分析
    • 新興參與者分析

第 7 章：生物製程驗證市場 - 按測試類型

  • 概述
    • 按測試類型分類的細分市場佔有率分析
    • 可萃取物和可浸出物測試
    • 生物過程殘留物測試
    • 病毒清除測試
    • 過濾和發酵系統測試
    • 其他

第 8 章：生物製程驗證市場 - 按製程組成部分

  • 概述
    • 按流程組件分類的細分市場佔有率分析
    • 過濾元件
    • 媒體容器和袋子
    • 冷凍和解凍工藝袋
    • 混合系統
    • 生物反應器
    • 傳輸系統
    • 其他

第 9 章：生物製程驗證市場 - 按最終用戶

  • 概述
    • 按最終用戶分類的細分市場佔有率分析
    • 製藥與生物技術公司
    • 合約開發和製造組織
    • 其他

第 10 章：生物製程驗證市場 - 按地理位置

  • 介紹
    • 按地理位置分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 北美生物製程驗證主要製造商
    • 北美市場規模和預測（按國家）
    • 北美市場規模和預測（按測試類型）
    • 北美市場規模和預測（按流程組件）
    • 北美市場規模和預測（按最終用戶）
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲生物製程驗證主要製造商
    • 歐洲市場規模和預測（按國家）
    • 歐洲市場規模和預測（按測試類型）
    • 歐洲市場規模和預測（按流程組件）
    • 歐洲市場規模和預測（按最終用戶）
    • 德國
    • 義大利
    • 英國
    • 法國
    • 俄羅斯
    • 荷蘭
    • 瑞典
    • 波蘭
    • 歐洲其他地區
  • 亞太地區 (APAC)
    • 概述
    • 亞太地區生物製程驗證主要製造商
    • 亞太地區市場規模與預測（按國家）
    • 按測試類型分類的亞太市場規模和預測
    • 亞太地區市場規模與預測（按流程組成部分）
    • 亞太地區市場規模和預測（按最終用戶）
    • 印度
    • 中國
    • 日本
    • 韓國
    • 澳洲
    • 泰國
    • 印尼
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲
    • 概述
    • 拉丁美洲生物製程驗證主要製造商
    • 拉丁美洲市場規模與預測（按國家）
    • 拉丁美洲市場規模和預測（按測試類型）
    • 拉丁美洲市場規模與預測（按流程組成部分）
    • 拉丁美洲市場規模和預測（按最終用戶）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲
    • 概述
    • 中東和非洲生物製程驗證主要製造商
    • 中東和非洲市場規模及預測（按國家）
    • 中東和非洲市場規模及預測（按測試類型）
    • 中東和非洲市場規模和預測（按流程組成部分）
    • 中東和非洲市場規模和預測（按最終用戶）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA 的其餘部分

第 11 章：主要供應商分析 - 生物製程驗證產業

  • 競爭儀表板
  • 公司簡介
    • Eurofins Scientific, Inc.
    • Sartorius AG
    • Merck KGaA
    • Thermo Fisher Scientific Inc.
    • Lonza
    • Danaher Corporation
    • Charles River Laboratories
    • SGS SA
    • Toxikon Corporation
    • Cobetter Filtration Equipment Co., Ltd.
    • Others

第 12 章：360 度分析師視角

第 13 章：附錄

  • 研究方法論
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
Product Code: ANV2456

REPORT HIGHLIGHT

Bioprocess validation Market size was valued at USD 420.91 Million in 2023, expanding at a CAGR of 9.83% from 2024 to 2032.

Bioprocess validation plays a vital role in guaranteeing the safety, quality, and effectiveness of bioproducts, including vaccines, antibodies, enzymes, and biosensors. Its purpose is to demonstrate that a bioprocess can consistently generate the desired bioproduct according to predetermined specifications and conditions. In the pharmaceutical industry, bioprocess validation is a mandatory regulatory requirement that ensures the uniformity and excellence of biopharmaceutical products throughout their entire lifespan.

Bioprocess validation Market- Market Dynamics

Surge in demand for outsourcing bioprocess validation and increase in life science R&D expenditure are expected to drive the market growth.

Numerous pharmaceutical and biotechnology companies are increasingly delegating various aspects of their operations, such as bioprocess validation. With the expansion of R&D activities in the life sciences sector, there is a rising demand for services related to bioprocess validation to facilitate the development and production of new biopharmaceutical products. Global expenditure on R&D has surged to nearly US$ 1.7 trillion, with approximately 10 countries contributing to 80% of the spending. As part of the Sustainable Development Goals (SDGs), nations have committed to significantly boosting public and private R&D expenditure, as well as the number of researchers, by 2030, as per the UNESCO Institute for Statistics (UIS). Additionally, advancements in bioprocessing technologies and regulatory compliance requirements may present growth opportunities for the market. Nonetheless, the high cost of validation could impede market growth.

Bioprocess validation Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 9.83% over the forecast period (2024-2032)

Based on Test Type segmentation, Extractables & Leachables Testing was predicted to show maximum market share in the year 2023

Based on Process Component segmentation, Filter Elements was the leading type in 2023

Based on End-User segmentation, Pharmaceutical & Biotechnology Companies was the leading type in 2023

On the basis of region, North America was the leading revenue generator in 2023

Bioprocess validation Market- Segmentation Analysis:

The Global Bioprocess validation Market is segmented on the basis of Test Type, Process Component, End-User, and Region.

The market is categorized into four groups according to the Test Type: Extractables & Leachables Testing, Bioprocess Residuals Testing, Viral Clearance Testing, Filtration & Fermentation Systems Testing, and Others. The dominant category in the market is Extractables & Leachables Testing. This type of testing plays a crucial role in the development and manufacturing of pharmaceutical products, especially when it comes to packaging materials, containers, and processing equipment used in biopharmaceutical production.

The market is segmented into five categories according to Process Component: Filter Elements, Media containers and bags, Freezing And Thawing Process Bags, Mixing Systems, Bioreactors, Transfer Systems and Others. Filter Elements are the leading category in the market. They play a vital role in biopharmaceutical manufacturing processes, especially in downstream processing.

The market is segmented into three groups according to the end-users: Pharmaceutical & Biotechnology Companies, Contract Development & Manufacturing Organizations, and Other. The dominant force in the market is the Pharmaceutical & Biotechnology Companies. These companies play a significant role in driving the demand for bioprocess validation services. Given their involvement in the development and production of biopharmaceutical products, it is crucial for them to maintain consistent quality and adhere to regulatory standards in their manufacturing processes.

Bioprocess validation Market- Geographical Insights

Geographically, this market spans across North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further segmented by countries contributing to business activities. The market is anticipated to be primarily driven by North America, particularly the United States, owing to the rising demand for Biopharmaceuticals. The United States boasts a strong and well-established biopharmaceutical industry. Validation of bioprocesses plays a critical role in ensuring the quality, safety, and effectiveness of biopharmaceutical products, leading to an increased demand for validation services and products. As per Pharmaceutical Statistics, the U.S. pharmaceutical industry recorded a revenue of $550 billion in 2021, while Americans spent USD 576.9 billion on medications. Europe stands as the second-largest region for market growth.

Bioprocess validation Market- Competitive Landscape:

The bioprocess validation market is experiencing substantial growth as a result of the rising need for biopharmaceuticals, advancements in bioprocess technology, and strict regulatory standards. Manufactures in this market are constantly striving to innovate and create cutting-edge technologies and methodologies for validating bioprocesses. By staying at the forefront of innovation, these companies gain a competitive advantage by providing validation solutions that are more efficient, accurate, and cost-effective. Additionally, companies that prioritize customer satisfaction and establish strong consumer relationships often benefit from repeat business and transfers, further enhancing their competitive position.

Recent Developments:

Eurofins BioPharma Product Testing Columbia part of the biggest network of harmonized bio/pharmaceutical GMP product testing facilities globally, announced a collaboration agreement with Plus Therapeutics, Inc. ("Plus Therapeutics"), a clinical stage pharmaceutical company developing novel, targeted therapies for rare and difficult cancers.

April 30, 2020, Merck, a leading science and technology company, today unveiled the next component of its BioContinuum Platform, the Bio4C Software Suite, generating a first-of-its-kind ecosystem that syndicates process control, analytics as well as plant-level automation.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL BIOPROCESS VALIDATION MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Eurofins Scientific, Inc.

Sartorius AG

Merck KGaA

Thermo Fisher Scientific Inc.

Lonza

Danaher Corporation

Charles River Laboratories

SGS S.A.

Toxikon Corporation

Cobetter Filtration Equipment Co., Ltd.

Others

GLOBAL BIOPROCESS VALIDATION MARKET, BY TEST TYPE- MARKET ANALYSIS, 2019 - 2032

  • Extractables & Leachables Testing
  • Bioprocess Residuals Testing
  • Viral Clearance Testing
  • Filtration & Fermentation Systems Testing
  • Others

GLOBAL BIOPROCESS VALIDATION MARKET, BY PROCESS COMPONENT- MARKET ANALYSIS, 2019 - 2032

  • Filter Elements
  • Media containers and bags
  • Freezing And Thawing Process Bags
  • Mixing Systems
  • Bioreactors
  • Transfer Systems
  • Others

GLOBAL BIOPROCESS VALIDATION MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Pharmaceutical & Biotechnology Companies
  • Contract Development & Manufacturing Organizations
  • Other

GLOBAL BIOPROCESS VALIDATION MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1.Bioprocess Validation Market Overview

  • 1.1.Study Scope
  • 1.2.Market Estimation Years

2.Executive Summary

  • 2.1.Market Snippet
    • 2.1.1.Bioprocess Validation Market Snippet by Test Type
    • 2.1.2.Bioprocess Validation Market Snippet by Process Component
    • 2.1.3.Bioprocess Validation Market Snippet by End-User
    • 2.1.4.Bioprocess Validation Market Snippet by Country
    • 2.1.5.Bioprocess Validation Market Snippet by Region
  • 2.2.Competitive Insights

3.Bioprocess Validation Key Market Trends

  • 3.1.Bioprocess Validation Market Drivers
    • 3.1.1.Impact Analysis of Market Drivers
  • 3.2.Bioprocess Validation Market Restraints
    • 3.2.1.Impact Analysis of Market Restraints
  • 3.3.Bioprocess Validation Market Opportunities
  • 3.4.Bioprocess Validation Market Future Trends

4.Bioprocess Validation Industry Study

  • 4.1.PEST Analysis
  • 4.2.Porter's Five Forces Analysis
  • 4.3.Growth Prospect Mapping
  • 4.4.Regulatory Framework Analysis

5.Bioprocess Validation Market: COVID-19 Impact Analysis

  • 5.1.Pre-COVID-19 Impact Analysis
  • 5.2.Post-COVID-19 Impact Analysis
    • 5.2.1.Top Performing Segments
    • 5.2.2.Marginal Growth Segments
    • 5.2.3.Top Looser Segments
    • 5.2.4.Marginal Loss Segments

6.Bioprocess Validation Market Landscape

  • 6.1.Bioprocess Validation Market Share Analysis, 2023
  • 6.2.Breakdown Data, by Key Manufacturer
    • 6.2.1.Established Players' Analysis
    • 6.2.2.Emerging Players' Analysis

7.Bioprocess Validation Market - By Test Type

  • 7.1.Overview
    • 7.1.1.Segment Share Analysis, By Test Type, 2023 & 2032 (%)
    • 7.1.2.Extractables & Leachables Testing
    • 7.1.3.Bioprocess Residuals Testing
    • 7.1.4.Viral Clearance Testing
    • 7.1.5.Filtration & Fermentation Systems Testing
    • 7.1.6.Others

8.Bioprocess Validation Market - By Process Component

  • 8.1.Overview
    • 8.1.1.Segment Share Analysis, By Process Component, 2023 & 2032 (%)
    • 8.1.2.Filter Elements
    • 8.1.3.Media containers and bags
    • 8.1.4.Freezing And Thawing Process Bags
    • 8.1.5.Mixing Systems
    • 8.1.6.Bioreactors
    • 8.1.7.Transfer Systems
    • 8.1.8.Others

9.Bioprocess Validation Market - By End-User

  • 9.1.Overview
    • 9.1.1.Segment Share Analysis, By End-User, 2023 & 2032 (%)
    • 9.1.2.Pharmaceutical & Biotechnology Companies
    • 9.1.3.Contract Development & Manufacturing Organizations
    • 9.1.4.Other

10.Bioprocess Validation Market- By Geography

  • 10.1.Introduction
    • 10.1.1.Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 10.2.North America
    • 10.2.1.Overview
    • 10.2.2.Bioprocess Validation Key Manufacturers in North America
    • 10.2.3.North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4.North America Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 10.2.5.North America Market Size and Forecast, By Process Component, 2019 - 2032 (US$ Million)
    • 10.2.6.North America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.2.7.U.S.
      • 10.2.7.1.Overview
      • 10.2.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3.U.S. Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.2.7.4.U.S. Market Size and Forecast, By Process Component, 2019 - 2032 (US$ Million)
      • 10.2.7.5.U.S. Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.2.8.Canada
      • 10.2.8.1.Overview
      • 10.2.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3.Canada Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.2.8.4.Canada Market Size and Forecast, By Process Component, 2019 - 2032 (US$ Million)
      • 10.2.8.5.Canada Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.3.Europe
    • 10.3.1.Overview
    • 10.3.2.Bioprocess Validation Key Manufacturers in Europe
    • 10.3.3.Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4.Europe Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 10.3.5.Europe Market Size and Forecast, By Process Component, 2019 - 2032 (US$ Million)
    • 10.3.6.Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.7.Germany
      • 10.3.7.1.Overview
      • 10.3.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3.Germany Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.7.4.Germany Market Size and Forecast, By Process Component, 2019 - 2032 (US$ Million)
      • 10.3.7.5.Germany Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.8.Italy
      • 10.3.8.1.Overview
      • 10.3.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3.Italy Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.8.4.Italy Market Size and Forecast, By Process Component, 2019 - 2032 (US$ Million)
      • 10.3.8.5.Italy Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.9.United Kingdom
      • 10.3.9.1.Overview
      • 10.3.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3.United Kingdom Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.9.4.United Kingdom Market Size and Forecast, By Process Component, 2019 - 2032 (US$ Million)
      • 10.3.9.5.United Kingdom Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.10.France
      • 10.3.10.1.Overview
      • 10.3.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3.France Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.10.4.France Market Size and Forecast, By Process Component, 2019 - 2032 (US$ Million)
      • 10.3.10.5.France Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.11.Russia
      • 10.3.11.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2.Russia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.11.3.Russia Market Size and Forecast, By Process Component, 2019 - 2032 (US$ Million)
      • 10.3.11.4.Russia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.12.Netherlands
      • 10.3.12.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2.Netherlands Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.12.3.Netherlands Market Size and Forecast, By Process Component, 2019 - 2032 (US$ Million)
      • 10.3.12.4.Netherlands Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.13.Sweden
      • 10.3.13.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2.Sweden Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.13.3.Sweden Market Size and Forecast, By Process Component, 2019 - 2032 (US$ Million)
      • 10.3.13.4.Sweden Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.14.Poland
      • 10.3.14.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2.Poland Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.14.3.Poland Market Size and Forecast, By Process Component, 2019 - 2032 (US$ Million)
      • 10.3.14.4.Poland Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.15.Rest of Europe
      • 10.3.15.1.Overview
      • 10.3.15.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3.Rest of the Europe Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.15.4.Rest of the Europe Market Size and Forecast, By Process Component, 2019 - 2032 (US$ Million)
      • 10.3.15.5.Rest of the Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.4.Asia Pacific (APAC)
    • 10.4.1.Overview
    • 10.4.2.Bioprocess Validation Key Manufacturers in Asia Pacific
    • 10.4.3.Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4.Asia Pacific Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 10.4.5.Asia Pacific Market Size and Forecast, By Process Component, 2019 - 2032 (US$ Million)
    • 10.4.6.Asia Pacific Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.7.India
      • 10.4.7.1.Overview
      • 10.4.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3.India Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.7.4.India Market Size and Forecast, By Process Component, 2019 - 2032 (US$ Million)
      • 10.4.7.5.India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.8.China
      • 10.4.8.1.Overview
      • 10.4.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3.China Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.8.4.China Market Size and Forecast, By Process Component, 2019 - 2032 (US$ Million)
      • 10.4.8.5.China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.9.Japan
      • 10.4.9.1.Overview
      • 10.4.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3.Japan Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.9.4.Japan Market Size and Forecast, By Process Component, 2019 - 2032 (US$ Million)
      • 10.4.9.5.Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.10.South Korea
      • 10.4.10.1.Overview
      • 10.4.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3.South Korea Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.10.4.South Korea Market Size and Forecast, By Process Component, 2019 - 2032 (US$ Million)
      • 10.4.10.5.South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.11.Australia
      • 10.4.11.1.Overview
      • 10.4.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3.Australia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.11.4.Australia Market Size and Forecast, By Process Component, 2019 - 2032 (US$ Million)
      • 10.4.11.5.Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.12.Thailand
      • 10.4.12.1.Overview
      • 10.4.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3.Thailand Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.12.4.Thailand Market Size and Forecast, By Process Component, 2019 - 2032 (US$ Million)
      • 10.4.12.5.Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.13.Indonesia
      • 10.4.13.1.Overview
      • 10.4.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3.Indonesia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.13.4.Indonesia Market Size and Forecast, By Process Component, 2019 - 2032 (US$ Million)
      • 10.4.13.5.Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.14.Philippines
      • 10.4.14.1.Overview
      • 10.4.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3.Philippines Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.14.4.Philippines Market Size and Forecast, By Process Component, 2019 - 2032 (US$ Million)
      • 10.4.14.5.Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.15.Rest of APAC
      • 10.4.15.1.Overview
      • 10.4.15.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3.Rest of APAC Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.15.4.Rest of APAC Market Size and Forecast, By Process Component, 2019 - 2032 (US$ Million)
      • 10.4.15.5.Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.5.Latin America
    • 10.5.1.Overview
    • 10.5.2.Bioprocess Validation Key Manufacturers in Latin America
    • 10.5.3.Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4.Latin America Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 10.5.5.Latin America Market Size and Forecast, By Process Component, 2019 - 2032 (US$ Million)
    • 10.5.6.Latin America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.7.Brazil
      • 10.5.7.1.Overview
      • 10.5.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3.Brazil Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.5.7.4.Brazil Market Size and Forecast, By Process Component, 2019 - 2032 (US$ Million)
      • 10.5.7.5.Brazil Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.8.Mexico
      • 10.5.8.1.Overview
      • 10.5.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3.Mexico Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.5.8.4.Mexico Market Size and Forecast, By Process Component, 2019 - 2032 (US$ Million)
      • 10.5.8.5.Mexico Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.9.Argentina
      • 10.5.9.1.Overview
      • 10.5.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3.Argentina Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.5.9.4.Argentina Market Size and Forecast, By Process Component, 2019 - 2032 (US$ Million)
      • 10.5.9.5.Argentina Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.10.Colombia
      • 10.5.10.1.Overview
      • 10.5.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3.Colombia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.5.10.4.Colombia Market Size and Forecast, By Process Component, 2019 - 2032 (US$ Million)
      • 10.5.10.5.Colombia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.11.Rest of LATAM
      • 10.5.11.1.Overview
      • 10.5.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3.Rest of LATAM Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.5.11.4.Rest of LATAM Market Size and Forecast, By Process Component, 2019 - 2032 (US$ Million)
      • 10.5.11.5.Rest of LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.6.Middle East and Africa
    • 10.6.1.Overview
    • 10.6.2.Bioprocess Validation Key Manufacturers in Middle East and Africa
    • 10.6.3.Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4.Middle East and Africa Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 10.6.5.Middle East and Africa Market Size and Forecast, By Process Component, 2019 - 2032 (US$ Million)
    • 10.6.6.Middle East and Africa Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.7.Saudi Arabia
      • 10.6.7.1.Overview
      • 10.6.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3.Saudi Arabia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.6.7.4.Saudi Arabia Market Size and Forecast, By Process Component, 2019 - 2032 (US$ Million)
      • 10.6.7.5.Saudi Arabia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.8.United Arab Emirates
      • 10.6.8.1.Overview
      • 10.6.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3.United Arab Emirates Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.6.8.4.United Arab Emirates Market Size and Forecast, By Process Component, 2019 - 2032 (US$ Million)
      • 10.6.8.5.United Arab Emirates Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.9.Israel
      • 10.6.9.1.Overview
      • 10.6.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3.Israel Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.6.9.4.Israel Market Size and Forecast, By Process Component, 2019 - 2032 (US$ Million)
      • 10.6.9.5.Israel Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.10.Turkey
      • 10.6.10.1.Overview
      • 10.6.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3.Turkey Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.6.10.4.Turkey Market Size and Forecast, By Process Component, 2019 - 2032 (US$ Million)
      • 10.6.10.5.Turkey Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.11.Algeria
      • 10.6.11.1.Overview
      • 10.6.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3.Algeria Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.6.11.4.Algeria Market Size and Forecast, By Process Component, 2019 - 2032 (US$ Million)
      • 10.6.11.5.Algeria Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.12.Egypt
      • 10.6.12.1.Overview
      • 10.6.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3.Egypt Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.6.12.4.Egypt Market Size and Forecast, By Process Component, 2019 - 2032 (US$ Million)
      • 10.6.12.5.Egypt Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.13.Rest of MEA
      • 10.6.13.1.Overview
      • 10.6.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3.Rest of MEA Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.6.13.4.Rest of MEA Market Size and Forecast, By Process Component, 2019 - 2032 (US$ Million)
      • 10.6.13.5.Rest of MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)

11.Key Vendor Analysis- Bioprocess Validation Industry

  • 11.1.Competitive Dashboard
  • 11.2.Company Profiles
    • 11.2.1.Eurofins Scientific, Inc.
    • 11.2.2.Sartorius AG
    • 11.2.3.Merck KGaA
    • 11.2.4.Thermo Fisher Scientific Inc.
    • 11.2.5.Lonza
    • 11.2.6.Danaher Corporation
    • 11.2.7.Charles River Laboratories
    • 11.2.8.SGS S.A.
    • 11.2.9.Toxikon Corporation
    • 11.2.10.Cobetter Filtration Equipment Co., Ltd.
    • 11.2.11.Others

12.360 Degree Analyst View

13.Appendix

  • 13.1.Research Methodology
  • 13.2.References
  • 13.3.Abbreviations
  • 13.4.Disclaimer
  • 13.5.Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Bioprocess Validation Market: Test Type Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Test Type
  • TABLE Global Bioprocess Validation Market, by Test Type 2019-2032 (USD Million)
  • TABLE Bioprocess Validation Market: Process Component Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Process Component
  • TABLE Global Bioprocess Validation Market, by Process Component 2019-2032 (USD Million)
  • TABLE Bioprocess Validation Market: End-User Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by End-User
  • TABLE Global Bioprocess Validation Market, by End-User 2019-2032 (USD Million)
  • TABLE Bioprocess Validation Market: Regional snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Bioprocess Validation Market, by Region 2019-2032 (USD Million)
  • TABLE North America Bioprocess Validation Market, by Country, 2019-2032 (USD Million)
  • TABLE North America Bioprocess Validation Market, by Test Type, 2019-2032 (USD Million)
  • TABLE North America Bioprocess Validation Market, by Process Component, 2019-2032 (USD Million)
  • TABLE North America Bioprocess Validation Market, by End-User, 2019-2032 (USD Million)
  • TABLE Europe Bioprocess Validation Market, by Country, 2019-2032 (USD Million)
  • TABLE Europe Bioprocess Validation Market, by Test Type, 2019-2032 (USD Million)
  • TABLE Europe Bioprocess Validation Market, by Process Component, 2019-2032 (USD Million)
  • TABLE Europe Bioprocess Validation Market, by End-User, 2019-2032 (USD Million)
  • TABLE Asia Pacific Bioprocess Validation Market, by Country, 2019-2032 (USD Million)
  • TABLE Asia Pacific Bioprocess Validation Market, by Test Type, 2019-2032 (USD Million)
  • TABLE Asia Pacific Bioprocess Validation Market, by Process Component, 2019-2032 (USD Million)
  • TABLE Asia Pacific Bioprocess Validation Market, by End-User, 2019-2032 (USD Million)
  • TABLE Latin America Bioprocess Validation Market, by Country, 2019-2032 (USD Million)
  • TABLE Latin America Bioprocess Validation Market, by Test Type, 2019-2032 (USD Million)
  • TABLE Latin America Bioprocess Validation Market, by Process Component, 2019-2032 (USD Million)
  • TABLE Latin America Bioprocess Validation Market, by End-User, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Bioprocess Validation Market, by Country, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Bioprocess Validation Market, by Test Type, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Bioprocess Validation Market, by Process Component, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Bioprocess Validation Market, by End-User, 2019-2032 (USD Million)